default author photo

Amit Awasthi

Government of India - Immuno-biology Lab

SCHOLARLY PAPERS

4

DOWNLOADS

1,110

TOTAL CITATIONS

11

Scholarly Papers (4)

Actions:
Email selected abstracts
1.

Cellular Immune Responses are Preserved and May Contribute to Chadox1 ChAdOx1 nCoV-19 Vaccine Effectiveness Against Infection Due to SARS-CoV-2 B·1·617·2 Delta Variant Despite Reduced Virus Neutralisation

Number of pages: 42 Posted: 16 Jul 2021
Ramachandran Thiruvengadam, Amit Awasthi, Guruprasad Medigeshi, Sankar Bhattacharya, Shailendra Mani, Sridhar Sivasubbu, Tripti Srivatsava, Sweety Samal, Deepika Rathna Murugesan, Bapu Koundinya Desiraju, Pallavi Kshetrapal, Rajesh Pandey, Vinod Scaria, Praveen Kumar Malik, Juhi Taneja, Akshay Binayke, Tarini Vohra, Aymaan Zaheer, Deepak Rathore, Naseem Ahmed Khan, Heena Shaman, Shubbir Ahmed, Rajesh Kumar, Suprit Deshpande, Chandru Subramani, Nitya Wadhwa, Nimesh Gupta, Anil K. Pandey, Jayanta Bhattacharya, Anurag Agrawal, Sudhanshu Vrati, Shinjini Bhatnagar, Pramod Kumar Garg and DBT Consortium for COVID-19 Research
Translational Health Science and Technology Institute, Government of India - Immuno-biology Lab, Government of India - Translational Health Science & Technology Institute (THSTI), Translational Health Science and Technology Institute, Government of India - Infection and Immunology Center, CSIR-Institute of Genomics and Integrative Biology, Translational Health Science and Technology Institute, Government of India - Infection and Immunology Center, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, CSIR-Institute of Genomics and Integrative Biology, CSIR-Institute of Genomics and Integrative Biology, ESIC Medical College and Hospital, ESIC Medical College and Hospital, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Government of India - Vaccine and Infectious Disease Research Center, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Regional Center for Biotechnology, Translational Health Science and Technology Institute, National Institute of Immunology, ESIC Medical College and Hospital, Translational Health Science and Technology Institute, CSIR-Institute of Genomics and Integrative Biology, Regional Center for Biotechnology, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute and Independent
Downloads 826 (73,650)
Citation 6

Abstract:

Loading...

2.

Omicron Sub-Lineage BA.5 Infection Causes Attenuated Pathology and Results in Robust Protection in Omicron Recovered hACE2 Transgenic Mice

Number of pages: 49 Posted: 10 Oct 2022
ZAIGHAM ABBAS RIZVI, Neeta Adhikari, Kritika Sharma, Srikanth Sadhu sadhu, Jyotsna Dandotiya, Ritika Khatri, Virendra Singh, Vinayakdas K.V., Sweety Samal, Shailendra Mani and Amit Awasthi
Government of India - Immuno-biology Lab, Government of India - Immuno-biology Lab, Government of India - Immuno-biology Lab, Government of India - Immuno-biology Lab, Government of India - Immuno-biology Lab, Government of India - Infection and Immunology Center, Government of India - Immuno-biology Lab, Government of India - Immuno-biology Lab, Government of India - Infection and Immunology Center, Government of India - Infection and Immunology Center and Government of India - Immuno-biology Lab
Downloads 161 (464,454)

Abstract:

Loading...

BA.5, Omicron sub-variants, Variant of concern, COVID-19, SARS-CoV-2, hACE2.Tg mice, re-infection

3.

Cell Mediated Immunity (CMI) for SARS-CoV-2 Infection Among General Population of North India: A Cross-Sectional Analysis from a Sub-Sample of a Large Sero-Epidemiological Study

Number of pages: 15 Posted: 18 Aug 2023
Dr. Puneet Misra, Pramod Garg, Amit Awasthi, Shashi Kant, Sanjay K. Rai, Mohammad Ahmad, Randeep Guleria, Trideep Jyoti Deori, Suprakash Mandal, Abhishek Jaiswal, Gaurav Gongal, Siddhesh Vishwakarma, Mohan Bairwa, Rakesh Kumar, Partha Haldar and Akshay Binayke
Department of Computer Science, All India Institute of Medical Sciences (AIIMS) - Department of Gastroenterology and Human Nutrition, Government of India - Immuno-biology Lab, All India Institute of Medical Sciences (AIIMS) - Department of Community and Family Medicine, All India Institute of Medical Sciences (AIIMS) - Department of Community and Family Medicine, World Health Organization (WHO) - World Health Organization (WHO) Country Office for Yemen, All India Institute of Medical Sciences (AIIMS), New Delhi, All India Institute of Medical Sciences (AIIMS), Bhopal, All India Institute of Medical Sciences (AIIMS), New Delhi - Centre for Community Medicine, All India Institute of Medical Sciences (AIIMS) - Department of Community and Family Medicine, All India Institute of Medical Sciences (AIIMS), Bhopal, Government of India - Translational Health Science & Technology Institute (THSTI), All India Institute of Medical Sciences (AIIMS) - Department of Community and Family Medicine, All India Institute of Medical Sciences (AIIMS), Bhopal, All India Institute of Medical Sciences (AIIMS) - Department of Community and Family Medicine and Translational Health Science and Technology Institute
Downloads 63 (933,592)

Abstract:

Loading...

SARS-CoV-2, Cell mediated immunity, COVID-19, T-cell mediated immunity, IFN-γ response

4.

Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion Inactivated SARS-CoV-2 Vaccine - BBV152

Number of pages: 45 Posted: 25 Nov 2020
Brunda Ganneru, Harsh Jogdand, Vijaya Kumar Daram, Narasimha Reddy Molugu, Sai D. Prasad, Srinivas V. Kannappa, Krishna M. Ella, Rajaram Ravikrishnan, Amit Awasthi, Jomy Jose, Panduranga Rao, Deepak Kumar, Raches Ella, Priya Abraham, Pragya Yadav, Gajanan N. Sapkal, Anita Shete, Gururaj Rao Desphande, Sreelekshmy Mohandas, Atanu Basu, Nivedita Gupta and Krishna Mohan Vadrevu
Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, RCC Labs, Government of India - Immuno-biology Lab, RCC Labs, Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), Indian Council of Medical Research (ICMR) and Bharat Biotech International Ltd
Downloads 60 (961,006)
Citation 5

Abstract:

Loading...

SARS-CoV-2; covid vaccine; COVID-19; covaxin; BBV152